Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Recent advances in understanding the biochemical and molecular mechanism of diabetic cardiomyopathy.

Liu JW, Liu D, Cui KZ, Xu Y, Li YB, Sun YM, Su Y.

Biochem Biophys Res Commun. 2012 Oct 26;427(3):441-3. doi: 10.1016/j.bbrc.2012.09.058. Epub 2012 Sep 18. Review.

PMID:
22995317
[PubMed - indexed for MEDLINE]
2.

Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.

Ola MS, Nawaz MI, Siddiquei MM, Al-Amro S, Abu El-Asrar AM.

J Diabetes Complications. 2012 Jan-Feb;26(1):56-64. doi: 10.1016/j.jdiacomp.2011.11.004. Epub 2012 Jan 5. Review.

PMID:
22226482
[PubMed - indexed for MEDLINE]
3.

Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy.

Sun YM, Su Y, Li J, Wang LF.

Biochem Biophys Res Commun. 2013 Apr 19;433(4):359-61. doi: 10.1016/j.bbrc.2013.02.120. Epub 2013 Mar 26. Review.

PMID:
23541575
[PubMed - indexed for MEDLINE]
4.

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.

Figueroa-Romero C, Sadidi M, Feldman EL.

Rev Endocr Metab Disord. 2008 Dec;9(4):301-14. doi: 10.1007/s11154-008-9104-2. Review.

PMID:
18709457
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy.

Obrosova IG, Julius UA.

Curr Vasc Pharmacol. 2005 Jul;3(3):267-83. Review.

PMID:
16026323
[PubMed - indexed for MEDLINE]
6.

Diabetic cardiomyopathy--fact or fiction?

Maisch B, Alter P, Pankuweit S.

Herz. 2011 Mar;36(2):102-15. doi: 10.1007/s00059-011-3429-4.

PMID:
21424347
[PubMed - indexed for MEDLINE]
7.

Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Falcão-Pires I, Leite-Moreira AF.

Heart Fail Rev. 2012 May;17(3):325-44. doi: 10.1007/s10741-011-9257-z. Review.

PMID:
21626163
[PubMed - indexed for MEDLINE]
8.

The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.

Kiss L, Szabó C.

Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:29-37. Epub 2005 Jun 14. Review.

PMID:
15962096
[PubMed - indexed for MEDLINE]
Free Article
9.

Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.

Farhangkhoee H, Khan ZA, Kaur H, Xin X, Chen S, Chakrabarti S.

Pharmacol Ther. 2006 Aug;111(2):384-99. Epub 2005 Dec 15. Review.

PMID:
16343639
[PubMed - indexed for MEDLINE]
10.

Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

Mortuza R, Chakrabarti S.

Heart Fail Rev. 2014 Jan;19(1):75-86. doi: 10.1007/s10741-013-9381-z. Review.

PMID:
23430126
[PubMed - indexed for MEDLINE]
11.

Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications.

Kota SK, Kota SK, Jammula S, Panda S, Modi KD.

Diabetes Technol Ther. 2011 Nov;13(11):1155-60. doi: 10.1089/dia.2011.0120. Epub 2011 Jul 13. Review.

PMID:
21751873
[PubMed - indexed for MEDLINE]
12.

Approaches to prevention of cardiovascular complications and events in diabetes mellitus.

Coccheri S.

Drugs. 2007;67(7):997-1026. Review.

PMID:
17488145
[PubMed - indexed for MEDLINE]
13.

Metabolic dysfunction in diabetic cardiomyopathy.

Isfort M, Stevens SC, Schaffer S, Jong CJ, Wold LE.

Heart Fail Rev. 2014 Jan;19(1):35-48. doi: 10.1007/s10741-013-9377-8. Review.

PMID:
23443849
[PubMed - indexed for MEDLINE]
14.

Diabetic cardiomyopathy--a distinct disease?

Khavandi K, Khavandi A, Asghar O, Greenstein A, Withers S, Heagerty AM, Malik RA.

Best Pract Res Clin Endocrinol Metab. 2009 Jun;23(3):347-60. doi: 10.1016/j.beem.2008.10.016. Review.

PMID:
19520308
[PubMed - indexed for MEDLINE]
15.

Oxidative stress and stress signaling: menace of diabetic cardiomyopathy.

Wold LE, Ceylan-Isik AF, Ren J.

Acta Pharmacol Sin. 2005 Aug;26(8):908-17. Review.

PMID:
16038622
[PubMed - indexed for MEDLINE]
Free Article
16.

Emerging role of epigenetics and miRNA in diabetic cardiomyopathy.

Asrih M, Steffens S.

Cardiovasc Pathol. 2013 Mar-Apr;22(2):117-25. doi: 10.1016/j.carpath.2012.07.004. Epub 2012 Aug 28. Review.

PMID:
22951386
[PubMed - indexed for MEDLINE]
17.

Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction.

Mabley JG, Soriano FG.

Curr Vasc Pharmacol. 2005 Jul;3(3):247-52. Review.

PMID:
16026321
[PubMed - indexed for MEDLINE]
18.

Aldose reductase / polyol inhibitors for diabetic retinopathy.

Obrosova IG, Kador PF.

Curr Pharm Biotechnol. 2011 Mar 1;12(3):373-85. Review.

PMID:
20939801
[PubMed - indexed for MEDLINE]
19.

Myocardial fatty acid metabolism and lipotoxicity in the setting of insulin resistance.

Kok BP, Brindley DN.

Heart Fail Clin. 2012 Oct;8(4):643-61. doi: 10.1016/j.hfc.2012.06.008. Epub 2012 Aug 9. Review.

PMID:
22999246
[PubMed - indexed for MEDLINE]
20.

Epigenetics and diabetic cardiomyopathy.

Singh GB, Sharma R, Khullar M.

Diabetes Res Clin Pract. 2011 Oct;94(1):14-21. doi: 10.1016/j.diabres.2011.05.033. Epub 2011 Jun 21. Review.

PMID:
21696841
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk